Regulation of immune responses by manipulation of intermediary metabolite levels

摘要: The present invention provides novel processes for regulating immune responses in mammalian subjects, e.g., humans, afflicted with diseases such as cancers, infections, viral bacterial or dysfunctions, especially auto-immune disorders, diabetes, Crohn's disease, rheumatoid arthritis, arteriosclerosis and ulcerative colitis. More particularly, this relates to generating elevated levels of an intermediary metabolite, lipids conjugated biomolecules, glycolipids, lipoproteins glycoproteins other than antibodies, cytokines hormones. Treatment can be carried by introduction the metabolite into subject a reagent that when administered leads levels. treatment regimen vivo ex vivo.